SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: Prospector who wrote (3027)7/12/1998 2:20:00 PM
From: Mr. Forthright  Respond to of 5402
 
Thanks for your post. Now here are some facts:

North American Averages (approval process)

Preclinical studies: 3.5 years

Phase I clinical trials: 1 year

Phase II clinical trials: 2 years

Phase III clinical trials: 3 years

Review process/approval: 2.5 years

Average total: 12 years